No headlines found.
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
Globe Newswire (Thu, 18-Apr 7:30 AM ET)
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
Globe Newswire (Tue, 16-Apr 7:00 AM ET)
OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row
Globe Newswire (Thu, 11-Apr 7:30 AM ET)
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
Globe Newswire (Mon, 25-Mar 7:30 AM ET)
Globe Newswire (Mon, 11-Mar 4:30 PM ET)
OptimizeRx Powers Walmart's 'Specialty Pharmacies of the Community' Outreach Effort
Globe Newswire (Mon, 4-Mar 3:51 PM ET)
OptimizeRx to Participate in Upcoming Investor Conferences
Globe Newswire (Wed, 21-Feb 7:30 AM ET)
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
Globe Newswire (Thu, 25-Jan 7:30 AM ET)
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Optimizerx trades on the NASDAQ stock market under the symbol OPRX.
As of April 25, 2024, OPRX stock price declined to $8.70 with 15,575 million shares trading.
OPRX has a beta of 2.91, meaning it tends to be more sensitive to market movements. OPRX has a correlation of 0.22 to the broad based SPY ETF.
OPRX has a market cap of $158.20 million. This is considered a Micro Cap stock.
Last quarter Optimizerx reported $28 million in Revenue and $.26 earnings per share. This beat revenue expectation by $2 million and met earnings estimates .
In the last 3 years, OPRX stock traded as high as $99.18 and as low as $6.92.
The top ETF exchange traded funds that OPRX belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
OPRX has underperformed the market in the last year with a price return of -44.3% while the SPY ETF gained +22.6%. OPRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -41.6% and -20.5%, respectively, while the SPY returned +3.1% and -2.9%, respectively.
OPRX support price is $8.83 and resistance is $9.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OPRX stock will trade within this expected range on the day.